HCPCS Level II
Q5105
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units
Codes near Q5105
These sit next to Q5105 in the CMS Level II file. All Q codes
- Q5100Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg
- Q5101Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
- Q5102Injection, infliximab, biosimilar, 10 mg
- Q5103Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg
- Q5104Injection, infliximab-abda, biosimilar, (renflexis), 10 mg
- Q5106Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
- Q5107Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
- Q5108Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
- Q5109Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
- Q5110Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00069-1305-10 | Retacrit | Pfizer Inc | 200 |
| 00069-1306-10 | Retacrit | Pfizer Inc | 300 |
| 00069-1307-10 | Retacrit | Pfizer Inc | 400 |
| 00069-1308-10 | Retacrit | Pfizer Inc | 1000 |
| 00069-1309-04 | Retacrit | Pfizer Inc | 1600 |
| 00069-1311-10 | Retacrit | Pfizer Inc | 2000 |
| 00069-1318-10 | Retacrit | Pfizer Inc | 1000 |
| 59353-0002-10 | Retacrit | Vifor (International) Inc. | 200 |
| 59353-0003-10 | Retacrit | Vifor (International) Inc. | 300 |
| 59353-0004-10 | Retacrit | Vifor (International) Inc. | 400 |
| 59353-0120-10 | Retacrit | Vifor (International) Inc. | 2000 |
| 59353-0220-10 | Retacrit | Vifor (International) Inc. | 1000 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.